Development of Subcutaneous Lecanemab: Establishing the Comparability of Subcutaneous and Intravenous Lecanemab Formulations
Subcutaneous injection of lecanemab using a vial or autoinjector yielded comparable average steady-state concentrations to intravenous administration of lecanemab in healthy patients.
Authors
- Shobha Dhadda (ORCID: https://orcid.org/0000-0002-7290-7168)
- Steven M. Hersch (ORCID: https://orcid.org/0000-0001-5948-6672)
- Sumit Rawal
- Lynn D. Kramer
- Jagadeesh Aluri
- Penner Natasha
- Larisa Reyderman
- Michael C. Irizarry
- David Li
Institutions
- Eisai (United States) (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_104694
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00